Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Epidemiology of Cytomegalovirus Infection after Transplantation and Immunosuppression
1975286 citationsMilan Fiala, John E. Payne et al.The Journal of Infectious Diseasesprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of W Henle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Henle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Henle more than expected).
This network shows the impact of papers produced by W Henle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Henle. The network helps show where W Henle may publish in the future.
Co-authorship network of co-authors of W Henle
This figure shows the co-authorship network connecting the top 25 collaborators of W Henle.
A scholar is included among the top collaborators of W Henle based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with W Henle. W Henle is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
11 of 11 papers shown
1.
Lanier, A, et al.. (1991). Epstein-Barr virus and malignant lymphoepithelial lesions of the salivary gland.. PubMed. 50(2). 55–61.25 indexed citations
2.
Berkel, A.I. van, W Henle, G Henle, et al.. (1985). Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.. PubMed. 19. 287–300.4 indexed citations
Masucci, Giuseppe, H Mellstedt, Maria G. Masucci, et al.. (1984). Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.. PubMed. 44(3). 1288–300.23 indexed citations
Levine, Pascale, Gary R. Pearson, M Armstrong, et al.. (1981). The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).. PubMed. 4(1-4). 307–12.10 indexed citations
Fiala, Milan, John E. Payne, Thomas V. Berne, et al.. (1975). Epidemiology of Cytomegalovirus Infection after Transplantation and Immunosuppression. The Journal of Infectious Diseases. 132(4). 421–433.286 indexed citations breakdown →
10.
Henle, W, et al.. (1973). Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors.. PubMed. 51(2). 361–9.108 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.